Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q4 2022 Earnings

23MarConfirmed

May 22

Aug 22

Nov 22

Q4 2022

-1.45

-1.39

-1.33

-1.27

Details

Expected EPS

-1.33

Actual EPS

-1.28

Surprise EPS

0.05

Surprise Percent

+3.76%

Description

Relmada Therapeutics (RLMD) has reported earnings of -1.28 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.